|Skip left side navigation and go to content||
NHLBI Small Business Program
The NHLBI Small Business Program enables US-owned and operated small businesses to engage in research and development on innovative and commercially promising products and services to prevent, diagnose, and treat heart, lung, and blood-related diseases and disorders.
Funding for small business research is available through the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) mechanisms. For an overview of these mechanisms, please visit ABOUT THE PROGRAMS. You can also explore current NHLBI SBIR/STTR funding opportunities here.
Staff from the NHLBI Office of Translational Alliances and Coordination (OTAC), are available to advise and mentor NHLBI SBIR/STTR applicants and awardees on matters relating to product development, regulatory affairs, intellectual property, product commercialization, licensing, and strategic partnerships.
FY2017 SBIR Contract Topics – Proposals Due October 21
NHLBI is seeking innovative technologies that fit five topics identified in PHS2017-1: remote/mobile/wireless technology for aging in place (topic 098);
ability to create inhaled peptide formulation (topic 099);
MRI myocardial needle chemoablation catheter (topic 100); membranous ventricular septal defect (pmVSD) transcatheter occluder system (topic 101);
and a transcatheter occluder device for paravalvular leaks (topic 102). Join the webinar on
August 24, 2016 to learn more about the contract proposal process and topics at NIH and CDC. Read more about the NHLBI contract topics.
Get Tips on Your Commercialization Plan and Regulatory StrategyWatch the NHLBI Small Biz Hangouts. Check out archived presentations
Last Updated November 2016
11/29 - 12/01 – SBIR STTR Innovation Summit - Austin, TX
12/03 - 12/06 – American Society of Hematology (2016 ASH) - San Diego, CA
01/09 - 01/11 – Biotech Showcase Conference 2017 - San Francisco, CA
01/10 – The Redefining Early Stage Investments (RESI) Conference - San Francisco, CA
02/13 - 02/14 – BIO CEO & Investor Conference - New York, NY